close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Nalu Medical, Inc.

News headline image
Nalu Announces Publication of Results from COMFORT Randomized Controlled Trial (RCT) Demonstrating Sustained Pain Relief and Functional Improvements Over 24 Months
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu Advances Wearable Neurostimulation with New, 39% Smaller Therapy Disc
From Nalu Medical, Inc.
Via Business Wire
News headline image
CareFirst BCBS Recognizes Nalu Neurostimulation System as Medically Necessary for Chronic Peripheral Pain, Expanding Access to 3.5 Million Covered Lives
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu Medical Achieves National Payer Milestone with Aetna Coverage for PNS Therapy
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu PNS System Significantly Reduces Healthcare-Related Costs in Chronic Pain Patients
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu 1-Year PNS Data Show Durable Pain Relief and Significant Functional Improvement
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu Medical, Inc. Closes $85 Million Series E Round
From Nalu Medical, Inc.
Via Business Wire
News headline image
CORRECTING and REPLACING Nalu Medical, Inc. Presents Long-term and Holistic Outcomes from the COMFORT RCT for PNS at NANS 2024
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu Medical, Inc. Presents Important New Clinical Data for PNS and SCS at ASPN 2023
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu Medical, Inc. Announces First Enrollment of COMFORT-2 Peripheral Nerve Stimulation Randomized Controlled Trial
From Nalu Medical, Inc.
Via Business Wire
News headline image
Nalu Medical, Inc., Announces Publication of Two Spinal Cord Stimulation Clinical Studies
From Nalu Medical, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today